Skip to main content
HONZ PHARMACEUTICAL CO., LTD. logo

HONZ PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 300086 ISIN · CNE100000QM6 LEI · 300300SA7ZULJ816T861 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,012 across all filing types
Latest filing 2018-10-29 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 300086

About HONZ PHARMACEUTICAL CO., LTD.

https://www.honz.com.cn

HONZ Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical products, with a specialized emphasis on pediatric healthcare. The company provides a diverse range of medications specifically formulated for children, including antipyretics, analgesics, respiratory treatments, and anti-infective agents. It utilizes advanced drug delivery systems and taste-masking technologies to enhance patient compliance and therapeutic efficacy. In addition to its pediatric portfolio, the organization produces various chemical drugs and traditional Chinese medicine preparations. The company maintains multiple production bases and research centers dedicated to advancing clinical solutions and ensuring high standards of product quality across its therapeutic categories.

Recent filings

Filing Released Lang Actions
2018年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2018 Third Quarter Report" of 康芝药业股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as total assets, net assets, revenue, net profit, earnings per share, and cash flow figures for the third quarter of 2018. It also includes shareholder information and explanations of significant changes in financial data. The length of the document (15,000 characters) and the presence of substantive financial statements and analysis confirm it is a comprehensive interim report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q3 2018
2018-10-29 Chinese
关于全资子公司获得《药品GMP证书》的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (797 characters) from 康芝药业股份有限公司 about its wholly-owned subsidiary receiving a new GMP certificate from the Hebei Food and Drug Administration. It is a regulatory compliance update related to certification, not a financial report or detailed management discussion. The document does not contain financial data, earnings, or management changes. It is an official announcement of a regulatory certificate issuance. Given the short length and nature, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2018-10-15 Chinese
2018年前三季度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast for the first three quarters of 2018, providing estimated net profit figures and explanations for changes. It explicitly states that the financial data is unaudited and that detailed financial data will be disclosed in the third quarter report. The document is short (1331 characters) and serves as a preliminary earnings forecast rather than a full financial report. It does not contain actual financial statements or comprehensive analysis, only projections and explanations. Therefore, it fits the category of an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights only. 9M 2018
2018-10-12 Chinese
关于2018年股票期权激励计划股票期权首次授予登记完成的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of the first registration of stock options granted under the company's 2018 stock option incentive plan. It details the approval process, the number of options granted, the recipients, the exercise price, and the performance conditions for exercising the options. The document is a formal public announcement about a capital incentive plan and stock option grant, not a full financial report or earnings release. It does not contain financial statements or detailed financial analysis but rather regulatory disclosures about stock option grants. This fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as stock option plans.
2018-10-10 Chinese
关于为全资子公司中山爱护日用品有限公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 康芝药业股份有限公司 regarding the provision of a guarantee for its wholly-owned subsidiary 中山爱护日用品有限公司. It details the guarantee agreement, the financial status of the subsidiary, approval procedures, risks, and cumulative guarantee amounts. The document is a formal disclosure about a financing-related guarantee arrangement rather than a financial report, earnings release, or management discussion. It does not contain comprehensive financial statements or detailed financial analysis but focuses on the guarantee and credit facility details. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company financing activities and guarantees.
2018-09-28 Chinese
关于获得药物临床试验批件的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement from 康芝药业股份有限公司 regarding the receipt of a clinical trial approval for a drug (注射用苏拉明钠) from the National Medical Products Administration (国家药品监督管理局). It details the drug information, project overview, treatment status, approval stage, market prospects, and risk warnings. The document is relatively short (1513 characters) and serves as an official announcement of a regulatory milestone rather than a financial report or detailed filing. It does not contain financial statements, audit information, or management discussion. It is not a report publication announcement since it contains substantive information about the clinical trial approval. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2018-09-11 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.